• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus.

作者信息

Tucker G T, Houston J B, Huang S M

机构信息

Molecular Pharmacology and Pharmacogenetics, Division of Clinical Sciences, University of Sheffield, The Royal Hallamshire Hospital, UK.

出版信息

Clin Pharmacol Ther. 2001 Aug;70(2):103-14. doi: 10.1067/mcp.2001.116891.

DOI:10.1067/mcp.2001.116891
PMID:11503003
Abstract
摘要

相似文献

1
Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus.
Clin Pharmacol Ther. 2001 Aug;70(2):103-14. doi: 10.1067/mcp.2001.116891.
2
EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences.
Eur J Pharm Sci. 2001 Jul;13(4):417-28. doi: 10.1016/s0928-0987(01)00148-8.
3
Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus.优化药物研发：评估药物代谢/转运体相互作用潜力的策略——迈向共识
Pharm Res. 2001 Aug;18(8):1071-80. doi: 10.1023/a:1010994022294.
4
Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--towards a consensus.优化药物研发：评估药物代谢/转运体相互作用潜力的策略——迈向共识
Br J Clin Pharmacol. 2001 Jul;52(1):107-17. doi: 10.1046/j.0306-5251.2001.temp.1441.x.
5
Pharmacokinetic drug interactions in liver disease: An update.肝病中的药代动力学药物相互作用：最新进展。
World J Gastroenterol. 2016 Jan 21;22(3):1260-78. doi: 10.3748/wjg.v22.i3.1260.
6
Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats.黄芪甲苷 IV 抑制肝微粒体中 CYP1A2 的活性，影响茶碱在大鼠体内的药代动力学。
J Pharm Pharmacol. 2013 Jan;65(1):149-55. doi: 10.1111/j.2042-7158.2012.01579.x. Epub 2012 Aug 29.
7
In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions.西地那非（伟哥）的体外生物转化：人细胞色素的鉴定及潜在药物相互作用
Drug Metab Dispos. 2000 Apr;28(4):392-7.
8
Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.丹参水提物对人体和大鼠咖啡因药代动力学及肝微粒体 CYP1A2 活性的影响。
J Pharm Pharmacol. 2010 Aug;62(8):1077-83. doi: 10.1111/j.2042-7158.2010.01127.x.
9
A proposal for avoiding toxic interactions of a drug under development to estimate inhibitory ability on the drug metabolizing enzymes in human liver.一项关于避免正在研发的药物产生毒性相互作用以评估其对人肝药物代谢酶抑制能力的提议。
J Toxicol Sci. 1996 Dec;21(5):317-21. doi: 10.2131/jts.21.5_317.
10
Biotransformation in review: applications in ocular disease and drug design.生物转化综述：在眼部疾病和药物设计中的应用
J Ocul Pharmacol Ther. 1996 Winter;12(4):527-39. doi: 10.1089/jop.1996.12.527.

引用本文的文献

1
Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug-Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards.通过细胞色素P450对竞争性抑制性代谢药物-药物相互作用的静态与动态模型预测：前进一步，后退两步。
Clin Pharmacokinet. 2025 Jan;64(1):155-170. doi: 10.1007/s40262-024-01457-1. Epub 2024 Dec 10.
2
Effect of on the pharmacokinetic profile of tofacitinib and the underlying mechanism.关于对托法替布药代动力学特征的影响及潜在机制。 （你提供的原文“Effect of on...”中“Effect of”后面似乎缺少具体内容）
Front Pharmacol. 2024 Apr 8;15:1351882. doi: 10.3389/fphar.2024.1351882. eCollection 2024.
3
Identification of the cytochrome P450 enzymes involved in the oxidative metabolism of trantinterol using ultra high-performance liquid chromatography coupled with tandem mass spectrometry.
使用超高效液相色谱-串联质谱法鉴定参与川丁特罗氧化代谢的细胞色素P450酶
RSC Adv. 2018 Oct 10;8(60):34764-34772. doi: 10.1039/c8ra06219f. eCollection 2018 Oct 4.
4
Understanding the relevance of herb-drug interaction studies with special focus on interplays: a prerequisite for integrative medicine.理解草药-药物相互作用研究的相关性，尤其关注相互作用：这是整合医学的一个先决条件。
Porto Biomed J. 2019 Mar 1;4(2):e15. doi: 10.1016/j.pbj.0000000000000015. eCollection 2019 Mar-Apr.
5
and Drug-Drug Interaction Study of the Effects of Ivermectin and Oxantel Pamoate on Tribendimidine.伊维菌素和奥硝唑对三苯双脒影响的药物相互作用研究。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.00762-18. Print 2019 Jan.
6
Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450.草药补充剂通过调节细胞色素 P450 介导的肝毒性。
Int J Mol Sci. 2017 Nov 8;18(11):2353. doi: 10.3390/ijms18112353.
7
Study of in-vitro metabolism of selected antibiotic drugs in human liver microsomes by liquid chromatography coupled with tandem mass spectrometry.采用液相色谱-串联质谱联用技术研究选定抗生素药物在人肝微粒体中的体外代谢。
Anal Bioanal Chem. 2016 Nov;408(29):8273-8287. doi: 10.1007/s00216-016-9929-6. Epub 2016 Oct 4.
8
Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir.使用多种探针评估泛基因型丙型肝炎病毒NS5A抑制剂维帕他韦的转运体和细胞色素P450介导的药物相互作用潜力。
Clin Pharmacokinet. 2016 May;55(5):605-13. doi: 10.1007/s40262-015-0334-7.
9
Severe liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes.严重的肝硬变通过降低靶基因的转录，显著降低 AhR 介导的大鼠细胞色素 P450 的诱导。
PLoS One. 2013 Apr 23;8(4):e61983. doi: 10.1371/journal.pone.0061983. Print 2013.
10
Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics.依非韦伦对美沙酮药代动力学和药效学影响的作用机制。
Clin Pharmacol Ther. 2012 Apr;91(4):673-84. doi: 10.1038/clpt.2011.276. Epub 2012 Mar 7.